Stock Performance Relative to Benchmarks
Johnson Pharmacare's share price has exhibited a marked decline over the past year and beyond, significantly lagging behind the Sensex. While the benchmark index has delivered a positive return of 6.1% over the last 12 months, Johnson Pharmacare's stock has fallen by nearly 49.6% during the same period. This stark contrast highlights the stock's vulnerability amid a generally bullish market environment.
Year-to-date figures further underscore this trend, with the stock down 47.4% compared to the Sensex's 8.96% gain. Even over a three-year horizon, the stock has declined by 15.5%, whereas the Sensex has surged by over 35%. Despite a notable five-year gain of 131.5%, outperforming the Sensex's 90.8% rise, the recent trajectory poi...
Read More





